SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-08-000048
Filing Date
2008-01-08
Accepted
2008-01-08 12:40:29
Documents
2
Period of Report
2008-01-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 37739
2 EXHIBIT 99.1 - PRESS RELEASE ex99-1.htm EX-99.1 12438
  Complete submission text file 0001341004-08-000048.txt   52120
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

IRS No.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51169 | Film No.: 08517229
SIC: 2834 Pharmaceutical Preparations